Division on Substance Use Disorders, New York State Psychiatric Institute and Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and Columbia, University Irving Medical Center, New York, NY, USA.
Subst Use Misuse. 2023;58(8):1014-1020. doi: 10.1080/10826084.2023.2201851. Epub 2023 Apr 20.
: Impulsivity is implicated in the development and maintenance of Cocaine Use Disorder (CUD). Less work has examined impulsivity's role on interest in initiating treatment, treatment adherence, or treatment response. No pharmacotherapies are approved for CUD, so efforts to understand and bolster the effects of psychotherapy are important in guiding and refining treatment. The present study examined the impact of impulsivity on interest in treatment, treatment initiation, treatment adherence, and treatment outcomes in individuals with CUD. Following the completion of a larger study on impulsivity and CUD participants were offered 14 sessions of (12 weeks) Cognitive Behavioral Relapse Prevention (CBT-RP). Before starting treatment, participants completed seven self-report and four behavioral measures of impulsivity. Sixty-eight healthy adults (36% female) with CUD (aged 49.4 ± 7.9) expressed an interest in treatment. : Greater scores on several self-report measures of impulsivity, and fewer difficulties with delayed gratification were associated with increased interest in treatment in both males and females. 55 participants attended at least 1 treatment session, while 13 participants did attend a single session. Individuals who attended at least one treatment session scored lower on measures of lack of perseverance and procrastination. Still, measures of impulsivity did not reliably predict session attendance nor the frequency of cocaine-positive urine samples throughout treatment. Males attended nearly twice as many treatment sessions as females despite nonsignificant associations between impulsivity in males and the number of sessions attended. Greater impulsivity in individuals with CUD was associated with expressing an interest in treatment, but not treatment adherence or response.
冲动性与可卡因使用障碍(CUD)的发展和维持有关。很少有研究探讨冲动性在治疗意向、治疗依从性或治疗反应方面的作用。目前还没有批准用于治疗 CUD 的药物疗法,因此,了解和增强心理治疗的效果对于指导和完善治疗非常重要。本研究考察了冲动性对 CUD 患者治疗意向、治疗启动、治疗依从性和治疗结果的影响。在完成一项关于冲动性和 CUD 的更大规模研究后,为参与者提供了 14 节(12 周)认知行为复发预防(CBT-RP)。在开始治疗之前,参与者完成了七项自我报告和四项冲动性的行为测量。68 名健康成年人(36%为女性)表示对 CUD 治疗感兴趣(年龄 49.4±7.9)。
在男性和女性中,几项自我报告的冲动性测量得分较高,以及延迟满足困难较少与对治疗的兴趣增加相关。55 名参与者至少参加了一次治疗,而 13 名参与者只参加了一次。至少参加一次治疗的参与者在缺乏毅力和拖延方面的得分较低。尽管冲动性测量在治疗期间无法可靠地预测治疗次数或可卡因阳性尿液样本的频率,但也无法预测治疗次数。尽管男性和参加治疗的次数之间没有显著关联,但男性参加的治疗次数几乎是女性的两倍。
CUD 患者的冲动性越高,表达治疗意向的可能性越大,但与治疗依从性或反应无关。